Repeat GammaTile Brachytherapy for Recurrent High-Grade Glioma
Author Information
Author(s): Muacevic Alexander, Adler John R, Zhang Jeff F, Mix Michael D, Shapiro Anna, Babu Harish
Primary Institution: Upstate University Hospital, Syracuse, USA
Conclusion
The patient achieved over 36 months of survival and good quality of life after repeat Cs-131 brachytherapy for recurrent glioblastoma.
Supporting Evidence
- The patient underwent two separate GammaTile implantations.
- The patient survived for 37 months from the initial diagnosis.
- No evident treatment-related toxicity was reported.
Takeaway
A patient with brain cancer had two treatments using a special type of radiation therapy and lived for more than three years after his diagnosis.
Methodology
The patient underwent repeat Cs-131 brachytherapy implantations after tumor resections.
Potential Biases
Selection bias may exist due to the unique clinical characteristics of the patient.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
The patient was a 62-year-old right-handed male.
Statistical Information
P-Value
p = 0.0063
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website